Cas:489-32-7 Icariin manufacturer & supplier

We serve Chemical Name:Icariin CAS:489-32-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Icariin

Chemical Name:Icariin
CAS.NO:489-32-7
Synonyms:ICARRIN;ICARIN;Icariin;Ieariline;Icariil;ICARIINE;Epimedim P.E;Icariln;Icraiin;4′-O-methyl-8-γ,γ-dimethylallylkaempferol-3-rhamnoside-7-glucoside
Molecular Formula:C33H40O15
Molecular Weight:676.662
HS Code:2932999099

Physical and Chemical Properties:
Melting point:223-225ºC
Boiling point:948.5±65.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.679
PSA:238.20000
Exact Mass:676.236694
LogP:2.48

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like ICARRIN chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4′-O-methyl-8-γ,γ-dimethylallylkaempferol-3-rhamnoside-7-glucoside physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4′-O-methyl-8-γ,γ-dimethylallylkaempferol-3-rhamnoside-7-glucoside Use and application,ICARRIN technical grade,usp/ep/jp grade.


Related News: The GLOW trial doesn’t yet have the answer to that question, but Tendler pointed to encouraging early evidence from the regimen’s phase 2 trial, dubbed CAPTIVATE. Among eight patients who progressed after stopping the fixed-duration combo, six responded to subsequent Imbruvica monotherapy, while the other two didn’t have a response report, according to data presented at the recent American Society of Clinical Oncology annual meeting. Icariin manufacturer The patient, who arrived from Wuhan, is ��stable and under medical care,�� the ministry said in a statement, adding there is ��no cause for concern�� for the public. Icariin supplier A number of factors influenced the decision by the U.S. Centers for Disease Control and Prevention, including the COVID-19 pandemic, too few facilities to quarantine dogs safely and three recent incidents where rabies-infected dogs were brought into the country, CNN reported. Icariin vendor A number of factors influenced the decision by the U.S. Centers for Disease Control and Prevention, including the COVID-19 pandemic, too few facilities to quarantine dogs safely and three recent incidents where rabies-infected dogs were brought into the country, CNN reported. Icariin factory A number of factors influenced the decision by the U.S. Centers for Disease Control and Prevention, including the COVID-19 pandemic, too few facilities to quarantine dogs safely and three recent incidents where rabies-infected dogs were brought into the country, CNN reported.